Circulating Stromal Cell Derived Factor-1α (SDF-1α) is Predictive of Distant Metastasis in Gastric Carcinoma

REFERENCES

• Balkwill F. Cancer and the chemokine network. Nat. Rev. Cancer 2004; 4: 540–550
   PubMed Web of Science ®Google Scholar
• Orimo A., Gupta P. B., Sgroi D. C., Arenzana-Seisdedos F., Delaunay T., Naeem R., Carey V. J., Richardson A. L., Weinberg R. A. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005; 121: 335–348
   PubMed Web of Science ®Google Scholar
• Littlepage L. E., Egeblad M., Werb Z. Coevolution of cancer and stromal cellular responses. Cancer Cell 2005; 7(6)499–500
   PubMed Web of Science ®Google Scholar
• Muller A., Homey B., Soto H., Ge N., Catron D., Buchanan M. E., McClanahan T., Murphy E., Yuan W., Wagner S. N., Barrera J. L., Mohar A., Verastegui E., Zlotnik A. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001; 410(6824)50–56
   PubMed Web of Science ®Google Scholar
• Murakami T., Maki W., Cardones A. R., Fang H., Tun Kyi A., Nestle F. O., Hwang S. T. Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells. Cancer Res. 2002; 62(24)7328–7334
   PubMed Web of Science ®Google Scholar
• Spano J. P., Andre F., Morat L., Sabatier L., Besse B., Combadiere C., Deterre P., Martin A., Azorin J., Valeyre D., Khayat D., Le Chevalier T., Soria J. C. Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome. Ann. Oncol. 2004; 15(4)613–617
   PubMed Web of Science ®Google Scholar
• Bachelder R. E., Wendt M. A., Mercurio A. M. Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res. 2002; 62(24)7203–7206
   PubMed Web of Science ®Google Scholar
• Zeelenberg I. S., Ruuls-Van Stalle L., Roos E. The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer Res. 2003; 63(13)3833–3839
   PubMed Web of Science ®Google Scholar
• Bertolini F., Dell'Agnola C., Mancuso P., Rabascio C., Burlini A., Monestiroli S., Gobbi A., Pruneri G., Martinelli G. CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin's lymphoma. Cancer Res. 2002; 62(11)3106–3112
   PubMed Web of Science ®Google Scholar
• Koshiba T., Hosotani R., Miyamoto Y., Ida J., Tsuji S., Nakajima S., Kawaguchi M., Kobayashi H., Doi R., Hori T., Fujii N., Imamura M. Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression. Clin. Cancer Res. 2000; 6(9)3530–3535
   PubMed Web of Science ®Google Scholar
• Geminder H., Sagi-Assif O., Goldberg L., Meshel T., Rechavi G., Witz I. P., Ben-Baruch A. A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma. J. Immunol. 2001; 167(8)4747–4757
   PubMed Web of Science ®Google Scholar
• Kryczek I., Lange A., Mottram P., Alvarez X., Cheng P., Hogan M., Moons L., Wei S., Zou L., Machelon V., Emilie D., Terrassa M., Lackner A., Curiel T. J., Carmeliet P., Zou W. CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers. Cancer Res. 2005; 65(2)465–472
   PubMed Web of Science ®Google Scholar
• Loeffler M., Kruger J. A., Niethammer A. G., Reisfeld R. A. Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake. J. Clin. Invest. 2006; 116(7)1955–1962
   PubMed Web of Science ®Google Scholar
• Wiseman B., Werb S., Stromal Z. effects on mammary gland development and breast cancer. Science 2002; 296(5570)1046–1049
   PubMed Web of Science ®Google Scholar
• Liotta L. A., Kohn E. C. The microenvironment of the tumour-host interface. Nature 2001; 411(6835)375–379
   PubMed Web of Science ®Google Scholar
• Pupa S. M., Menard S., Forti S., Tagliabue E. New insights into the role of extracellular matrix during tumor onset and progression. J. Cell. Physiol. 2002; 192(3)259–267
   PubMed Web of Science ®Google Scholar
• Scotton C. J., Wilson J. L., Milliken D., Stamp G., Balkwill F. R. Epithelial cancer cell migration: a role for chemokine receptors?. Cancer Res. 2001; 61(13)4961–4965
   PubMed Web of Science ®Google Scholar
• Sanz-Rodriguez F., Hidalgo A., Teixido J. Chemokine stromal cell-derived factor-1alpha modulates VLA-4 integrin-mediated multiple myeloma cell adhesion to CS-1/fibronectin and VCAM-1. Blood 2001; 97(2)346–351
   PubMed Web of Science ®Google Scholar
• Yu X., Huang Y., Collin-Osdoby P., Osdoby P. Stromal cell-derived factor-1 (SDF-1) recruits osteoclast precursors by inducing chemotaxis, matrix metalloproteinase-9 (MMP-9) activity, and collagen transmigration. J. Bone Miner. Res. 2003; 18(8)1404–1418
   PubMed Web of Science ®Google Scholar
• Kollet O., Shivtiel S., Chen Y. Q., Suriawinata J., Thung S. N., Dabeva M. D., Kahn J., Spiegel A., Dar A., Samira S., Goichberg P., Kalinkovich A., Arenzana-Seisdedos F., Nagler A., Hardan I., Revel M., Shafritz D. A., Lapidot T. HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. J. Clin. Invest. 2003; 112(2)160–169
   PubMed Web of Science ®Google Scholar
• Strieter R. M. Chemokines: not just leukocyte chemoattractants in the promotion of cancer. Nat. Immunol. 2001; 2(4)285–286
   PubMed Web of Science ®Google Scholar
• Murphy P. M. Chemokines and the molecular basis of cancer metastasis. N. Engl. J. Med. 2001; 345(11)833–835
   PubMed Web of Science ®Google Scholar
• Taichman R. S., Cooper C., Keller E. T., Pienta K. J., Taichman N. S., McCauley L. K. Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res. 2002; 62(6)1832–1837
   PubMed Web of Science ®Google Scholar
• Yasumoto K., Koizumi K., Kawashima A., Saitoh Y., Arita Y., Shinohara K., Minami T., Nakayama T., Sakurai H., Takahashi Y., Yoshie O., Saiki I. Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer. Cancer Res. 2006; 66(4)2181–2187
   PubMed Web of Science ®Google Scholar
• Phillips R. J., Burdick M. D., Lutz M., Belperio J. A., Keane M. P., Strieter R. M. The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. Am. J. Respir. Crit. Care Med. 2003; 167(12)1676–1686
   PubMed Web of Science ®Google Scholar
• Kijowski J., Baj-Krzyworzeka M., Majka M., Reca R., Marquez L. A., Christofidou-Solomidou M., Janowska-Wieczorek A., Ratajczak M. Z. The SDF-1-CXCR4 axis stimulates VEGF secretion and activates integrins but does not affect proliferation and survival in lymphohematopoietic cells. Stem. Cells. 2001; 19(5)453–466
   PubMed Web of Science ®Google Scholar
• Salcedo R., Wasserman K., Young H. A., Grimm M. C., Howard O. M., Anver M. R., Kleinman H. K., Murphy W., Oppenheim J., Vascular J. J. endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha. Am. J. Pathol. 1999; 154(4)1125–1135
   PubMed Web of Science ®Google Scholar
• Hartmann T. N., Burger J. A., Glodek A., Fujii N., Burger M. CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells. Oncogene. 2005; 24(27)4462–4471
   PubMed Web of Science ®Google Scholar